Latest Tenpoint Therapeutics News & Updates

See the latest news and media coverage for Tenpoint Therapeutics. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Tenpoint Therapeutics

Eye therapeutics developer for aging vision disorders

tenpointtherapeutics.com
Headquarters
Irvine, United States
Founded year
2019
Company type
Private company
Number of employees
125–200
Industry
Pharmaceuticals

Last updated

Latest news about Tenpoint Therapeutics

In short: Tenpoint Therapeutics received FDA approval and launched YUVEZZI, its dual-agent eye drop for presbyopia, following a merger and financing.

Company announcements

Tenpoint Therapeutics

Tenpoint Therapeutics announces YUVEZZI™ availability in U.S.

YUVEZZI™ is carbachol and brimonidine tartrate ophthalmic solution 2.75%/0.1%.

Unlock all announcements with a

Media coverage

Yahoo Finance

Tenpoint Therapeutics Ltd and PHIL Partner to Launch YUVEZZI™ Direct-to-Patient Cash Program to Make Novel Presbyopia Therapy More Accessible and Affordable

Tenpoint Therapeutics, a leading ophthalmic manufacturer, and PHIL Inc., an all-in-one digital hub and Direct-to-Patient platform, today announced the launch of a Direct-to-Patient (DTP) cash...

Unlock all articles with a

Never miss news about Tenpoint Therapeutics

Track Tenpoint Therapeutics and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Tenpoint Therapeutics competitors & trending companies

Browse news for competitors to Tenpoint Therapeutics and other trending companies.